Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.

Sham JG, Kievit FM, Grierson JR, Miyaoka RS, Yeh MM, Zhang M, Yeung RS, Minoshima S, Park JO.

J Nucl Med. 2014 May;55(5):799-804. doi: 10.2967/jnumed.113.132118. Epub 2014 Mar 13.

PMID:
24627434
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).

Grierson JR, Brockenbrough JS, Rasey JS, Wiens L, Vesselle H.

Nucleosides Nucleotides Nucleic Acids. 2010 Jan;29(1):49-54. doi: 10.1080/15257770903451603.

PMID:
20391192
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.

Brockenbrough JS, Rasey JS, Grierson JR, Wiens LW, Vesselle H.

Nucl Med Biol. 2007 Aug;34(6):619-23.

PMID:
17707801
[PubMed - indexed for MEDLINE]
5.

Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.

Grierson JR, Brockenbrough JS, Rasey JS, Wiens LW, Schwartz JL, Jordan R, Vesselle H.

Nucl Med Biol. 2007 Jul;34(5):471-8. Epub 2007 May 11.

PMID:
17591546
[PubMed - indexed for MEDLINE]
6.

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

Muzi M, Spence AM, O'Sullivan F, Mankoff DA, Wells JM, Grierson JR, Link JM, Krohn KA.

J Nucl Med. 2006 Oct;47(10):1612-21.

PMID:
17015896
[PubMed - indexed for MEDLINE]
Free Article
7.

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.

Rajendran JG, Schwartz DL, O'Sullivan J, Peterson LM, Ng P, Scharnhorst J, Grierson JR, Krohn KA.

Clin Cancer Res. 2006 Sep 15;12(18):5435-41.

PMID:
17000677
[PubMed - indexed for MEDLINE]
Free Article
8.

Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.

Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, Gibson DF, Krohn KA.

J Nucl Med. 2005 Apr;46(4):658-66.

PMID:
15809489
[PubMed - indexed for MEDLINE]
Free Article
9.

Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.

Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, Krohn KA.

J Nucl Med. 2005 Feb;46(2):371-80.

PMID:
15695799
[PubMed - indexed for MEDLINE]
Free Article
10.

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson L, Wells JM, Krohn KA.

J Nucl Med. 2005 Feb;46(2):274-82.

PMID:
15695787
[PubMed - indexed for MEDLINE]
Free Article
11.

Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.

Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA.

Nucl Med Biol. 2004 Oct;31(7):829-37.

PMID:
15464384
[PubMed - indexed for MEDLINE]
12.

Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.

Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA.

Nucl Med Biol. 2004 May;31(4):419-23.

PMID:
15093811
[PubMed - indexed for MEDLINE]
13.

Production of [F-18]fluoroannexin for imaging apoptosis with PET.

Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, Link JM, Krohn KA.

Bioconjug Chem. 2004 Mar-Apr;15(2):373-9.

PMID:
15025534
[PubMed - indexed for MEDLINE]
14.

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA.

J Nucl Med. 2003 Dec;44(12):2027-32.

PMID:
14660729
[PubMed - indexed for MEDLINE]
Free Article
15.

Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogs.

Shields AF, Grierson JR, Muzik O, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, Mangner TJ.

Mol Imaging Biol. 2002 Jan;4(1):83-9.

PMID:
14538051
[PubMed]
16.

[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, Krohn KA.

Eur J Nucl Med Mol Imaging. 2003 May;30(5):695-704. Epub 2003 Mar 11.

PMID:
12632200
[PubMed - indexed for MEDLINE]
17.

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL.

J Nucl Med. 2002 Sep;43(9):1210-7.

PMID:
12215561
[PubMed - indexed for MEDLINE]
Free Article
18.

New routes to N-alkylated cyclic sulfamidates.

Posakony JJ, Grierson JR, Tewson TJ.

J Org Chem. 2002 Jul 26;67(15):5164-9.

PMID:
12126401
[PubMed - indexed for MEDLINE]
19.

Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo.

Grierson JR, Shields AF.

Nucl Med Biol. 2000 Feb;27(2):143-56.

PMID:
10773543
[PubMed - indexed for MEDLINE]
20.

The role of imaging in the development of oncologic agents.

Shields AF, Ho PT, Grierson JR.

J Clin Pharmacol. 1999 Aug;Suppl:40S-44S. Review. No abstract available.

PMID:
10434247
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk